Aileen B Chen

Summary

Affiliation: Massachusetts General Hospital
Country: USA

Publications

  1. doi request reprint Comparative effectiveness research in radiation oncology: assessing technology
    Aileen B Chen
    Department of Radiation Oncology, Dana Farber Cancer Institute, Boston, MA Department of Radiation Oncology, Brigham and Women s Hospital, Boston, MA Electronic address
    Semin Radiat Oncol 24:25-34. 2014
  2. pmc Palliative radiation therapy practice in patients with metastatic non-small-cell lung cancer: a Cancer Care Outcomes Research and Surveillance Consortium (CanCORS) Study
    Aileen B Chen
    Dana Farber Cancer Institute, 450 Brookline Ave, D1111, Boston, MA 02215, USA
    J Clin Oncol 31:558-64. 2013
  3. pmc Cost effectiveness and screening interval of lipid screening in Hodgkin's lymphoma survivors
    Aileen B Chen
    Department of Radiation Oncology, Dana Farber Cancer Institute and Brigham and Women s Hospital, Boston, MA 02115, USA
    J Clin Oncol 27:5383-9. 2009
  4. doi request reprint Survival outcomes after radiation therapy for stage III non-small-cell lung cancer after adoption of computed tomography-based simulation
    Aileen B Chen
    Dana Farber Cancer Institute, 44 Binney Street, Boston, MA 02115, USA
    J Clin Oncol 29:2305-11. 2011
  5. doi request reprint Comparative effectiveness of three platinum-doublet chemotherapy regimens in elderly patients with advanced non-small cell lung cancer
    Junya Zhu
    Center for Patient Safety, Dana Farber Cancer Institute, Boston, MA 02215, USA
    Cancer 119:2048-60. 2013
  6. pmc Expectations about the effectiveness of radiation therapy among patients with incurable lung cancer
    Aileen B Chen
    Dana Farber Cancer Institute, 450 Brookline Ave, D1111, Boston, MA 02215, USA
    J Clin Oncol 31:2730-5. 2013
  7. doi request reprint Clinical utility of 4D FDG-PET/CT scans in radiation treatment planning
    Michalis Aristophanous
    Department of Radiation Oncology, Dana Farber Brigham and Women s Cancer Center and Harvard Medical School, Boston, MA 02115, USA
    Int J Radiat Oncol Biol Phys 82:e99-105. 2012
  8. pmc Carboplatin and paclitaxel with vs without bevacizumab in older patients with advanced non-small cell lung cancer
    Junya Zhu
    Center for Patient Safety, Dana Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, USA
    JAMA 307:1593-601. 2012
  9. doi request reprint Evaluating FDG uptake changes between pre and post therapy respiratory gated PET scans
    Michalis Aristophanous
    Department of Radiation Oncology, Dana Farber Brigham and Women s Cancer Center and Harvard Medical School, Boston, MA, USA
    Radiother Oncol 102:377-82. 2012
  10. doi request reprint Predictors of IMRT and conformal radiotherapy use in head and neck squamous cell carcinoma: a SEER-Medicare analysis
    David J Sher
    Department of Radiation Oncology, Dana Farber Cancer Institute and Brigham and Women s Hospital, Boston, MA 02115, USA
    Int J Radiat Oncol Biol Phys 81:e197-206. 2011

Detail Information

Publications17

  1. doi request reprint Comparative effectiveness research in radiation oncology: assessing technology
    Aileen B Chen
    Department of Radiation Oncology, Dana Farber Cancer Institute, Boston, MA Department of Radiation Oncology, Brigham and Women s Hospital, Boston, MA Electronic address
    Semin Radiat Oncol 24:25-34. 2014
    ....
  2. pmc Palliative radiation therapy practice in patients with metastatic non-small-cell lung cancer: a Cancer Care Outcomes Research and Surveillance Consortium (CanCORS) Study
    Aileen B Chen
    Dana Farber Cancer Institute, 450 Brookline Ave, D1111, Boston, MA 02215, USA
    J Clin Oncol 31:558-64. 2013
    ..We investigated population-based patterns in the use of palliative RT among patients with metastatic non-small-cell lung cancer (NSCLC)...
  3. pmc Cost effectiveness and screening interval of lipid screening in Hodgkin's lymphoma survivors
    Aileen B Chen
    Department of Radiation Oncology, Dana Farber Cancer Institute and Brigham and Women s Hospital, Boston, MA 02115, USA
    J Clin Oncol 27:5383-9. 2009
    ..We evaluated the cost effectiveness of lipid screening in survivors of HL and compared different screening intervals...
  4. doi request reprint Survival outcomes after radiation therapy for stage III non-small-cell lung cancer after adoption of computed tomography-based simulation
    Aileen B Chen
    Dana Farber Cancer Institute, 44 Binney Street, Boston, MA 02115, USA
    J Clin Oncol 29:2305-11. 2011
    ..Technical studies suggest that computed tomography (CT) -based simulation improves the therapeutic ratio for thoracic radiation therapy (TRT), although few studies have evaluated its use or impact on outcomes...
  5. doi request reprint Comparative effectiveness of three platinum-doublet chemotherapy regimens in elderly patients with advanced non-small cell lung cancer
    Junya Zhu
    Center for Patient Safety, Dana Farber Cancer Institute, Boston, MA 02215, USA
    Cancer 119:2048-60. 2013
    ..Their relative effectiveness and comparability based on squamous versus nonsquamous histology is uncertain...
  6. pmc Expectations about the effectiveness of radiation therapy among patients with incurable lung cancer
    Aileen B Chen
    Dana Farber Cancer Institute, 450 Brookline Ave, D1111, Boston, MA 02215, USA
    J Clin Oncol 31:2730-5. 2013
    ..Although radiation therapy (RT) can palliate symptoms and may prolong life, it is not curative for patients with metastatic lung cancer. We investigated patient expectations about the goals of RT for incurable lung cancers...
  7. doi request reprint Clinical utility of 4D FDG-PET/CT scans in radiation treatment planning
    Michalis Aristophanous
    Department of Radiation Oncology, Dana Farber Brigham and Women s Cancer Center and Harvard Medical School, Boston, MA 02115, USA
    Int J Radiat Oncol Biol Phys 82:e99-105. 2012
    ..The potential role of four-dimensional (4D) positron emission tomography (PET)/computed tomography (CT) in radiation treatment planning, relative to standard three-dimensional (3D) PET/CT, was examined...
  8. pmc Carboplatin and paclitaxel with vs without bevacizumab in older patients with advanced non-small cell lung cancer
    Junya Zhu
    Center for Patient Safety, Dana Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, USA
    JAMA 307:1593-601. 2012
    ..However, longer survival was not observed in the subgroup of patients aged 65 years or older...
  9. doi request reprint Evaluating FDG uptake changes between pre and post therapy respiratory gated PET scans
    Michalis Aristophanous
    Department of Radiation Oncology, Dana Farber Brigham and Women s Cancer Center and Harvard Medical School, Boston, MA, USA
    Radiother Oncol 102:377-82. 2012
    ....
  10. doi request reprint Predictors of IMRT and conformal radiotherapy use in head and neck squamous cell carcinoma: a SEER-Medicare analysis
    David J Sher
    Department of Radiation Oncology, Dana Farber Cancer Institute and Brigham and Women s Hospital, Boston, MA 02115, USA
    Int J Radiat Oncol Biol Phys 81:e197-206. 2011
    ....
  11. doi request reprint Comparative effectiveness of intensity-modulated versus 3D conformal radiation therapy among medicare patients with stage III lung cancer
    Aileen B Chen
    Dana Farber Cancer Institute and Brigham and Women s Hospital, Boston, MA and Dana Farber Cancer Institute, Boston, MA
    J Thorac Oncol 9:1788-95. 2014
    ..The clinical benefit of intensity-modulated radiation therapy (IMRT) compared to 3D conformal radiation (3D-RT) has not been well established for locally advanced non-small-cell lung cancer (NSCLC)...
  12. pmc Outcomes by tumor histology and KRAS mutation status after lung stereotactic body radiation therapy for early-stage non-small-cell lung cancer
    Raymond H Mak
    Department of Radiation Oncology, Dana Farber Cancer Institute, Brigham and Women s Hospital, Boston, MA Harvard Medical School, Boston, MA Electronic address
    Clin Lung Cancer 16:24-32. 2015
    ..We analyzed outcomes after lung stereotactic body radiotherapy (SBRT) for early-stage non-small cell lung-carcinoma (NSCLC) by histology and KRAS genotype...
  13. pmc Comparison of texture features derived from static and respiratory-gated PET images in non-small cell lung cancer
    Stephen Yip
    Department of Radiation Oncology, Brigham and Women s Hospital, Dana Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States of America
    PLoS ONE 9:e115510. 2014
    ..We investigated the sensitivity of texture features to tumor motion by comparing static (3D) and respiratory-gated (4D) PET imaging...
  14. doi request reprint Employment and insurance in survivors of Hodgkin lymphoma and their siblings: a questionnaire study
    Aileen B Chen
    Department of Radiation Oncology, Dana Farber Cancer Institute, Boston, MA 02215, USA
    Leuk Lymphoma 53:1474-80. 2012
    ..Compared to their siblings, HL survivors may face greater challenges in obtaining employment and insurance. Late effects from treatment, including permanent cosmetic changes, may contribute to these differences...
  15. pmc Chemotherapy for locally advanced and metastatic pulmonary carcinoid tumors
    Curtis R Chong
    Department of Medical Oncology, Dana Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, United States
    Lung Cancer 86:241-6. 2014
    ..The optimal management of locally advanced and metastatic pulmonary carcinoid tumors remains to be determined...
  16. pmc Aggressive therapy for patients with non-small cell lung carcinoma and synchronous brain-only oligometastatic disease is associated with long-term survival
    Phillip J Gray
    Harvard Radiation Oncology Program, Boston, USA
    Lung Cancer 85:239-44. 2014
    ..We sought to analyze the effect of differing therapeutic paradigms in this subpopulation...
  17. doi request reprint Four-dimensional positron emission tomography: implications for dose painting of high-uptake regions
    Michalis Aristophanous
    Departments of Radiation Oncology, Dana Farber Brigham and Women s Cancer Center and Harvard Medical School, Boston, MA 02115, USA
    Int J Radiat Oncol Biol Phys 80:900-8. 2011
    ..To investigate the behavior of tumor subvolumes of high [18F]-fluorodeoxyglucose (FDG) uptake as seen on clinical four-dimensional (4D) FDG-positron emission tomography (PET) scans...